140 related articles for article (PubMed ID: 22841820)
1. Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment.
Khoufache K; Bondza PK; Harir N; Daris M; Leboeuf M; Mailloux J; Lemyre M; Foster W; Akoum A
Am J Pathol; 2012 Oct; 181(4):1197-205. PubMed ID: 22841820
[TBL] [Abstract][Full Text] [Related]
2. Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology.
Guay S; Akoum A
Reproduction; 2007 Sep; 134(3):525-34. PubMed ID: 17709570
[TBL] [Abstract][Full Text] [Related]
3. Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis.
Akoum A; Lawson C; Herrmann-Lavoie C; Maheux R
Hum Reprod; 2007 May; 22(5):1464-73. PubMed ID: 17324958
[TBL] [Abstract][Full Text] [Related]
4. Abnormal interleukin 1 receptor types I and II gene expression in eutopic and ectopic endometrial tissues of women with endometriosis.
Lawson C; Bourcier N; Al-Akoum M; Maheux R; Naud F; Akoum A
J Reprod Immunol; 2008 Jan; 77(1):75-84. PubMed ID: 17517439
[TBL] [Abstract][Full Text] [Related]
5. Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis.
Bellehumeur C; Collette T; Maheux R; Mailloux J; Villeneuve M; Akoum A
Hum Reprod; 2005 May; 20(5):1177-84. PubMed ID: 15705625
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways.
Veillat V; Carli C; Metz CN; Al-Abed Y; Naccache PH; Akoum A
J Clin Endocrinol Metab; 2010 Dec; 95(12):E403-12. PubMed ID: 20829186
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy.
Novella-Maestre E; Carda C; Ruiz-Sauri A; Garcia-Velasco JA; Simon C; Pellicer A
Biol Reprod; 2010 Nov; 83(5):866-73. PubMed ID: 20574053
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons.
Kyama CM; Overbergh L; Mihalyi A; Cuneo S; Chai D; Debrock S; Mwenda JM; Mathieu C; Nugent NP; D'Hooghe TM
Fertil Steril; 2008 May; 89(5 Suppl):1306-13. PubMed ID: 18061171
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis.
Herrmann Lavoie C; Fraser D; Therriault MJ; Akoum A
Am J Reprod Immunol; 2007 Dec; 58(6):505-13. PubMed ID: 17997749
[TBL] [Abstract][Full Text] [Related]
10. [Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model].
Wang DB; Zhang SL; Niu HY; Lu JM
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):759-62. PubMed ID: 15634503
[TBL] [Abstract][Full Text] [Related]
11. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 1alpha and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis.
Hudelist G; Lass H; Keckstein J; Walter I; Wieser F; Wenzl R; Mueller R; Czerwenka K; Kubista E; Singer CF
Hum Reprod; 2005 Jun; 20(6):1695-701. PubMed ID: 15746198
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis.
Moggio A; Pittatore G; Cassoni P; Marchino GL; Revelli A; Bussolati B
Fertil Steril; 2012 Dec; 98(6):1521-30.e2. PubMed ID: 22981172
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development.
Rakhila H; Girard K; Leboeuf M; Lemyre M; Akoum A
PLoS One; 2014; 9(10):e110434. PubMed ID: 25329068
[TBL] [Abstract][Full Text] [Related]
15. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.
Hull ML; Prentice A; Wang DY; Butt RP; Phillips SC; Smith SK; Charnock-Jones DS
Hum Reprod; 2005 Feb; 20(2):350-8. PubMed ID: 15567877
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo.
Khoufache K; Bazin S; Girard K; Guillemette J; Roy MC; Verreault JP; Al-Abed Y; Foster W; Akoum A
PLoS One; 2012; 7(5):e37264. PubMed ID: 22649515
[TBL] [Abstract][Full Text] [Related]
17. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.
Kyama CM; Overbergh L; Mihalyi A; Meuleman C; Mwenda JM; Mathieu C; D'Hooghe TM
Fertil Steril; 2008 Feb; 89(2):301-10. PubMed ID: 17678915
[TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
19. The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and survival of human endometrial implants in the nude mice endometriosis model.
Kayisli UA; Berkkanoglu M; Zhang L; Kizilay G; Arici A
Reprod Sci; 2007 Dec; 14(8):825-35. PubMed ID: 18089601
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
